Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001.

    Article  Google Scholar 

  2. Correa C, Harris EE, Leonardi MC, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73–9.

    Article  Google Scholar 

  3. Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.

    Article  Google Scholar 

  4. Polgár C, Ott OJ, Hildebrandt G, et al. Late side effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:259–68.

    Article  Google Scholar 

  5. Sawaki M, Sato S, Kikumori T, et al. A phase I study of intraoperative radiotherapy for early breast cancer in Japan. World J Surg. 2009;33:2587–92.

    Article  Google Scholar 

  6. Sawaki M, Sato S, Noda S, et al. Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan. Breast Cancer. 2012;19:353–9.

    Article  Google Scholar 

  7. Sawaki M, Kondo N, Horio A, et al. Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review. Breast Cancer. 2014;21:415–22.

    Article  Google Scholar 

  8. Sawaki M, Miyamoto T, Fujisawa T, et al. Multicenter phase II study of intraoperative radiotherapy of early breast cancer: Ipsilateral tumor recurrence. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07350-7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

    Masataka Sawaki MD, PhD & Hiroji Iwata MD, PhD

  2. Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

    Takeshi Kodaira MD, PhD

Authors
  1. Masataka Sawaki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeshi Kodaira MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroji Iwata MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masataka Sawaki MD, PhD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections off a brief invited commentary on the article, Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07350-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sawaki, M., Kodaira, T. & Iwata, H. ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence. Ann Surg Oncol 26 (Suppl 3), 660–661 (2019). https://doi.org/10.1245/s10434-019-07658-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07658-4

Search

Navigation